Abstract
A novel papain inhibitory protein (SPI) from Streptomyces mobaraensis was studied to measure its inhibitory effect on bacterial cysteine protease activity (Staphylococcus aureus SspB) and culture supernatants (Porphyromonas gingivalis, Bacillus anthracis). Further, growth of Bacillus anthracis, Staphylococcus aureus, Pseudomonas aeruginosa, and Vibrio cholerae was completely inhibited by 10 μM SPI. At this concentration of SPI, no cytotoxicity was observed. We conclude that SPI inhibits bacterial virulence factors and has the potential to become a novel therapeutic treatment against a range of unrelated pathogenic bacteria. Copyright © 2013, American Society for Microbiology.
Cite
CITATION STYLE
Zindel, S., Kaman, W. E., Fröls, S., Pfeifer, F., Peters, A., Hays, J. P., & Fuchsbauer, H. L. (2013). The papain inhibitor (SPI) of Streptomyces mobaraensis inhibits bacterial cysteine proteases and is an antagonist of bacterial growth. Antimicrobial Agents and Chemotherapy, 57(7), 3388–3391. https://doi.org/10.1128/AAC.00129-13
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.